Elamipretide
Elamipretide, sold under the brand name Forzinity, is a medication used for the treatment of Barth syndrome.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Elamipretide, sold under the brand name Forzinity, is a medication used for the treatment of Barth syndrome. Elamipretide is a mitochondrial cardiolipin binder. It is used as the hydrochloride salt.
It is given by injection under the skin (subcutaneous). The most common side effects identified in clinical trials include mild-to-moderate injection site reactions. Elamipretide was approved for medical use in the United States in September 2025.
The US Food and Drug Administration considers it to be a first-in-class medication.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1365399842 under CC BY-SA 4.0; modifications have been made.